PMC:7172841 / 5000-5410 JSONTXT

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T3","span":{"begin":328,"end":333},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0002542"}],"text":"ne activation and dysregulation between SARS-CoV-2 and other known severe infections in three patient cohorts: 104 patients with sepsis caused by bacterial CAP; 21 historical patients with 2009 H1N1 influenza; and 54 patients with CAP caused by SARS-CoV-2. Patients with bacterial CAP were screened for participation in a large-scale randomized clinical trial with the acronym PROVIDE (ClinicalTrials.gov NCT03"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T58","span":{"begin":40,"end":48},"obj":"Disease"},{"id":"T59","span":{"begin":40,"end":44},"obj":"Disease"},{"id":"T60","span":{"begin":74,"end":87},"obj":"Disease"},{"id":"T61","span":{"begin":194,"end":208},"obj":"Disease"},{"id":"T62","span":{"begin":199,"end":208},"obj":"Disease"},{"id":"T63","span":{"begin":245,"end":253},"obj":"Disease"},{"id":"T64","span":{"begin":245,"end":249},"obj":"Disease"}],"attributes":[{"id":"A58","pred":"mondo_id","subj":"T58","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A59","pred":"mondo_id","subj":"T59","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A60","pred":"mondo_id","subj":"T60","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A61","pred":"mondo_id","subj":"T61","obj":"http://purl.obolibrary.org/obo/MONDO_0005460"},{"id":"A62","pred":"mondo_id","subj":"T62","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A63","pred":"mondo_id","subj":"T63","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A64","pred":"mondo_id","subj":"T64","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"ne activation and dysregulation between SARS-CoV-2 and other known severe infections in three patient cohorts: 104 patients with sepsis caused by bacterial CAP; 21 historical patients with 2009 H1N1 influenza; and 54 patients with CAP caused by SARS-CoV-2. Patients with bacterial CAP were screened for participation in a large-scale randomized clinical trial with the acronym PROVIDE (ClinicalTrials.gov NCT03"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T37","span":{"begin":3,"end":13},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T38","span":{"begin":320,"end":321},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"ne activation and dysregulation between SARS-CoV-2 and other known severe infections in three patient cohorts: 104 patients with sepsis caused by bacterial CAP; 21 historical patients with 2009 H1N1 influenza; and 54 patients with CAP caused by SARS-CoV-2. Patients with bacterial CAP were screened for participation in a large-scale randomized clinical trial with the acronym PROVIDE (ClinicalTrials.gov NCT03"}

{"project":"LitCovid-sentences","denotations":[{"id":"T41","span":{"begin":111,"end":256},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ne activation and dysregulation between SARS-CoV-2 and other known severe infections in three patient cohorts: 104 patients with sepsis caused by bacterial CAP; 21 historical patients with 2009 H1N1 influenza; and 54 patients with CAP caused by SARS-CoV-2. Patients with bacterial CAP were screened for participation in a large-scale randomized clinical trial with the acronym PROVIDE (ClinicalTrials.gov NCT03"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T29","span":{"begin":67,"end":84},"obj":"Phenotype"},{"id":"T30","span":{"begin":129,"end":135},"obj":"Phenotype"}],"attributes":[{"id":"A29","pred":"hp_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/HP_0032169"},{"id":"A30","pred":"hp_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/HP_0100806"}],"text":"ne activation and dysregulation between SARS-CoV-2 and other known severe infections in three patient cohorts: 104 patients with sepsis caused by bacterial CAP; 21 historical patients with 2009 H1N1 influenza; and 54 patients with CAP caused by SARS-CoV-2. Patients with bacterial CAP were screened for participation in a large-scale randomized clinical trial with the acronym PROVIDE (ClinicalTrials.gov NCT03"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T129","span":{"begin":3,"end":13},"obj":"GO:0042110"},{"id":"T130","span":{"begin":18,"end":31},"obj":"GO:0065007"},{"id":"T131","span":{"begin":40,"end":50},"obj":"SP_7"},{"id":"T132","span":{"begin":146,"end":155},"obj":"NCBITaxon:2"},{"id":"T133","span":{"begin":245,"end":255},"obj":"SP_7"},{"id":"T134","span":{"begin":271,"end":280},"obj":"NCBITaxon:2"}],"text":"ne activation and dysregulation between SARS-CoV-2 and other known severe infections in three patient cohorts: 104 patients with sepsis caused by bacterial CAP; 21 historical patients with 2009 H1N1 influenza; and 54 patients with CAP caused by SARS-CoV-2. Patients with bacterial CAP were screened for participation in a large-scale randomized clinical trial with the acronym PROVIDE (ClinicalTrials.gov NCT03"}

{"project":"LitCovid-PubTator","denotations":[{"id":"284","span":{"begin":40,"end":50},"obj":"Species"},{"id":"285","span":{"begin":94,"end":101},"obj":"Species"},{"id":"286","span":{"begin":115,"end":123},"obj":"Species"},{"id":"287","span":{"begin":175,"end":183},"obj":"Species"},{"id":"288","span":{"begin":194,"end":198},"obj":"Species"},{"id":"289","span":{"begin":217,"end":225},"obj":"Species"},{"id":"290","span":{"begin":245,"end":255},"obj":"Species"},{"id":"291","span":{"begin":257,"end":265},"obj":"Species"},{"id":"304","span":{"begin":199,"end":208},"obj":"Species"},{"id":"306","span":{"begin":74,"end":84},"obj":"Disease"},{"id":"307","span":{"begin":129,"end":135},"obj":"Disease"}],"attributes":[{"id":"A284","pred":"tao:has_database_id","subj":"284","obj":"Tax:2697049"},{"id":"A285","pred":"tao:has_database_id","subj":"285","obj":"Tax:9606"},{"id":"A286","pred":"tao:has_database_id","subj":"286","obj":"Tax:9606"},{"id":"A287","pred":"tao:has_database_id","subj":"287","obj":"Tax:9606"},{"id":"A288","pred":"tao:has_database_id","subj":"288","obj":"Tax:114727"},{"id":"A289","pred":"tao:has_database_id","subj":"289","obj":"Tax:9606"},{"id":"A290","pred":"tao:has_database_id","subj":"290","obj":"Tax:2697049"},{"id":"A291","pred":"tao:has_database_id","subj":"291","obj":"Tax:9606"},{"id":"A304","pred":"tao:has_database_id","subj":"304","obj":"Tax:11309"},{"id":"A306","pred":"tao:has_database_id","subj":"306","obj":"MESH:D007239"},{"id":"A307","pred":"tao:has_database_id","subj":"307","obj":"MESH:D018805"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ne activation and dysregulation between SARS-CoV-2 and other known severe infections in three patient cohorts: 104 patients with sepsis caused by bacterial CAP; 21 historical patients with 2009 H1N1 influenza; and 54 patients with CAP caused by SARS-CoV-2. Patients with bacterial CAP were screened for participation in a large-scale randomized clinical trial with the acronym PROVIDE (ClinicalTrials.gov NCT03"}